UFP Technologies, Inc. Deferred Revenue, Revenue Recognized
UFP Technologies, Inc. (UFPT) reported Deferred Revenue, Revenue Recognized of $527.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2018-11-09
- 2018-09-30: Deferred Revenue, Revenue Recognized 9 month $527.00K.
- 2018-06-30: Deferred Revenue, Revenue Recognized 6 month $437.00K.
| Period end | Deferred Revenue, Revenue Recognized 6 month | Deferred Revenue, Revenue Recognized 9 month |
|---|---|---|
| 2018-09-30 | $527.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $437.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |